The latest market report published by Credence Research, Inc. “Structural Heart Devices Market By Type (Heart Valve Devices, Repair Devices, Accessories), By Procedure (Repair Procedures, Replacement Procedures) – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global structural heart devices market was valued at US$ 7.5 Bn in 2017 and expected to reach US$ 18.9 Bn by 2026, expanding at a CAGR of 10.7% from 2018 to 2026.
Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/structural-heart-devices-market
Market Insights
Structural heart diseases are non-coronary abnormalities comprise conditions which are either congenital or due to certain abnormalities developed in heart valves, and vessels due to age or underlying conditions. Common conditions respective to heart structure include paravalvular leak, ventricular septal defect, arterial venous fistulae, patent foramen oval, and so on. Significantly large prevalence of cardiovascular abnormalities. In the U.S. alone approximately 60 million individuals presenting 20% of the total population suffers from structural heart defects. This represents a significant opportunity for the use of structural heart devices. These conditions present a wide category of treatment including both repair and replacement procedures, for both acquired and congenital diseases.
Favorable reimbursements for the novel minimally invasive procedures have made procedures such as TAVR highly popular and affordable to the patients. As the global population is aging, the medical expenditure in several countries is being covered by the government and private insurers. This eases the per capita healthcare burden, therefore urging more and more patients to opt for such treatments. Furthermore, increasing awareness about the novel procedures and increasing availability of long-lasting implants drive the global market growth.
The major market players are also increasing their investments in research and development activities to enhance the effectiveness of these devices. It is expected that by 2020 some prominent and advanced pipeline products shall be commercialized. Boston Scientific Corporation, Abbott Laboratories, Medtronic, Edwards Lifesciences Corporation are some of the leading companies in this space.
Based on the type of devices, the global structural heart devices market is segmented into heart valve devices, repair devices and accessories. Among these the demand for heart valve devices is set to be the highest during the forecast period. Similarly, the replacement procedures segment in terms of procedure types is estimated to undergo the fastest market growth. Consistent growth in geriatric population, rapid adoption of transcatheter aortic valve replacement therapies, and affordable process of replacement procedures contribute to the rapid growth of this segment. Additionally, North America and Asia Pacific markets are the most prominent regions to watch during the forecast period in terms of revenue and market growth respectively. Asia Pacific region will progress at the fastest CAGR during the forecast period. Considering the competitive landscape, the global structural heart valve devices has rapidly changing dynamics. The new market entrants with promising pipeline devices are often being acquired by incumbent players with rich financial pool. The existing players are also strengthening their geographical foothold through mergers, distribution agreements and other growth strategies.
In addition this report provides profiles of key players operating in this market such as Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic PLC, LivaNova PLC, C. R. Bard, Inc., CryoLife, Inc., Integer Holdings Corporation, Comed B.V. and JenaValve Technology, Inc.
Key Market Movements:
- Growing incidence of congenital heart defects, and high prevalence of age related structural conditions
- Growing awareness and reducing procedure costs in Asia Pacific
- Intensifying market entry of major market players from developed countries to emerging Asia Pacific region
- Growing demand for minimally invasive procedures therefore paving way for transcatheter procedures
You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59510
Report Scope by Segments
By Type (2016–2026; US$ Mn)
- Heart Valve Devices
- Surgical Heart Valves
- Transcatheter Heart Valves
- Repair Devices
- Occluders and Delivery Systems
- Annuloplasty Rings
- Others
- Accessories
By Procedure (2016–2026; US$ Mn)
- Repair Procedures
- Valvuloplasty
- Transcatheter Mitral Valve Repair (TMVR)
- Annuloplasty
- Others
- Replacement Procedures
- Tissue Heart Valves
- Mechanical Heart Valves
- Transcatheter Aortic Valve Replacement (TAVR)
By Geography Segment (2016-2026; US$ Mn)
- North America
- Europe
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- Latin America
About Credence Research (Original Publisher)
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290
E-mail: sales@credenceresearch.com
Website: http://www.credenceresearch.com
No comments:
Post a Comment